PALVELLA THERAPEUTICS, INC. ($PVLA)
Filing Information
| Accession Number | 0001104659-26-018136 |
|---|---|
| Form Type | 4 |
| Filing Date | Feb 20, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
12,906
Total Value
$376,447.65
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Common Stock | โ | Feb 18, 2026 | Exercise/Conversion | 2,154 | $7.14 | $15,379.56 | 2,154 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Feb 18, 2026 | Exercise/Conversion | 2,148 | $9.08 | $19,503.84 | 4,302 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Feb 18, 2026 | Sale | 3,026 | $79.16 | $239,528.78 | 1,276 | Direct | โ | View Details | |
Chief Operating Officer | Common Stock | โ | Feb 18, 2026 | Sale | 1,276 | $79.97 | $102,035.47 | 0 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Feb 18, 2026 | Exercise/Conversion | 2,154 | $0.00 | $0.00 | 17,243 | Direct | โ | View Details | |
Chief Operating Officer | Stock Option (Right to Buy) | Derivative | Feb 18, 2026 | Exercise/Conversion | 2,148 | $0.00 | $0.00 | 17,184 | Direct | โ | View Details |